Hepatocellular carcinoma (HCC) is a highly malignant tumor found in the bile duct epithelial
cells, and the second most common tumor of the liver. However, the pivotal roles of most …

Hepatocellular carcinoma (HCC) remains hard to diagnose early and cure due to a lack of
accurate biomarkers and effective treatments. Hence, it is necessary to explore the …

A further understanding of the molecular mechanism of hepatocellular carcinoma (HCC) is
necessary to predict a patient's prognosis and develop new targeted gene drugs. This study …

Hepatocellular carcinoma (HCC) is a common malignancy. However, the molecular
mechanisms of the progression and prognosis of HCC remain unclear. In the current study …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer‑related deaths among
cancer patients. Genes correlated with the progression and prognosis of HCC are critically …

Hepatocellular carcinoma (HCC) is a common malignant tumor of the digestive system, and
its early asymptomatic characteristic increases the difficulty of diagnosis and treatment. This …

Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver, with high
morbidity and mortality, yet its molecular mechanisms of tumorigenesis are still unclear. In …

Simple Summary Liver cancer is one of the most common cancers; however, the molecular
mechanisms of liver tumorigenesis and progression are not completely understood. In the …

Hepatocellular carcinoma (HCC) is the most common subtype in liver cancer whose
prognosis is affected by malignant progression associated with complex gene interactions …

Hepatocellular carcinoma (HCC) is a widespread, common type of cancer in Asian
countries, and the need for biomarker-matched molecularly targeted therapy for HCC has …